Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q3 FY20 results · Oct–Dec 2019
Caplin Point Laboratories reported revenue from operations of ₹228.21 crore and net profit of ₹58.88 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 228.21 | — | — | — | — |
| Other income | 10.34 | — | — | — | — |
| Total income | 238.55 | — | — | — | — |
| Profit before tax | 69.62 | — | — | — | — |
| Net profit for the period | 58.88 | — | — | — | — |
| Attributable to shareholders of the company | 58.56 | — | — | — | — |
| EPS, basic (₹) | 7.74 | — | — | — | — |
| Net margin (%) | 25.8 | — | — |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 154.17 | 139.76 | +10.3% | 133.26 | +15.7% |
| Other income | 8.43 | 7.37 | +14.5% | 4.58 | +84.0% |
| Total income | 162.61 | 147.13 | +10.5% | 137.84 | +18.0% |
| Profit before tax | 60.59 | 50.86 | +19.1% | 52.69 | +15.0% |
| Net profit for the period | 47.59 | 36.86 | +29.1% | 39.79 | +19.6% |
| EPS, basic (₹) | 6.29 | 4.88 | +28.9% | 5.26 | +19.6% |
| Net margin (%) | 30.9 | 26.4 | 29.9 |
Consolidated
- Filed with BSE
- 07 Feb 2020, 12:00 IST
- Board meeting
- 05 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Feb 2020, 12:00 IST
- Board meeting
- 05 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE